Personalis - 5 Year Stock Price History | PSNL

Historical daily share price chart and data for Personalis since 2019 adjusted for splits and dividends. The latest closing stock price for Personalis as of October 31, 2024 is 5.05.
  • The all-time high Personalis stock closing price was 51.02 on January 20, 2021.
  • The Personalis 52-week high stock price is 7.20, which is 42.6% above the current share price.
  • The Personalis 52-week low stock price is 0.89, which is 82.4% below the current share price.
  • The average Personalis stock price for the last 52 weeks is 2.46.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Personalis Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 2.6401 2.0400 6.3400 1.1500 5.0500 140.48%
2023 2.0337 2.0100 4.1700 0.9301 2.1000 6.06%
2022 5.4195 14.3000 14.3000 1.7800 1.9800 -86.12%
2021 23.5645 34.7800 51.0200 12.2400 14.2700 -61.02%
2020 17.7151 10.9100 44.0000 4.7500 36.6100 235.87%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.270B $0.073B
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Bausch Health Cos (BHC) Canada $3.590B 2.61
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00